Bank Julius Baer & Co’s VolitionRx Ltd VNRX Stock Holding History

Bank Julius Baer & Co’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,382	Closed	-$201K	–	600
2022 Q3	$201K	Buy	+7,382	New	+$279K	﹤0.01%	404

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank Julius Baer & Co's VNRX Position: Q4 2022 in Review

Bank Julius Baer & Co sold out of VolitionRx Ltd (VNRX) in Q4 2022, closing a stake of 7,382 shares — an estimated $201K sold.

Bank Julius Baer & Co first reported a position in VNRX in Q3 2022 and held it in 1 quarter. The position peaked at $201K in Q3 2022. 34 funds tracked by Wall St. Rank hold VNRX as of Q4 2022.

Bank Julius Baer & Co reported no remaining VolitionRx Ltd position as of Q4 2022 after selling out during the quarter.
Bank Julius Baer & Co sold 7,382 VolitionRx Ltd shares in Q4 2022, an estimated $201K.
Bank Julius Baer & Co first reported a position in VolitionRx Ltd in Q3 2022 and held it in 1 quarter.
Bank Julius Baer & Co's VolitionRx Ltd position peaked at $201K in Q3 2022.
34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2022.

Based on Bank Julius Baer & Co's 13F filing for Q4 2022, filed 24 Jan 2023.